Open Access
E3S Web Conf.
Volume 233, 2021
2020 2nd International Academic Exchange Conference on Science and Technology Innovation (IAECST 2020)
Article Number 02048
Number of page(s) 4
Section BFS2020-Biotechnology and Food Science
Published online 27 January 2021
  1. Amer E I, Mossallam S F, Mahrous H. Therapeutic enhancement of newly derived bacteriocins against Giardia lamblia[J]. Experimental Parasitology, 2014, 146:52-63. [CrossRef] [PubMed] [Google Scholar]
  2. Pintong A R, Ruangsittichai J, Ampawong S, et al. Efficacy of Ageratum conyzoides extracts against Giardia duodenalis trophozoites: an experimental study[J]. BMC Complementary Medicine and Therapies, 2020, 20(1). [Google Scholar]
  3. Vivancos V, González-Alvarez, I, Bermejo M, et al. Giardiasis: Characteristics, Pathogenesis and New Insights About Treatment[J]. Current Topics in Medicinal Chemistry, 2018. [Google Scholar]
  4. Leung A, Leung A, Wong A, et al. Giardiasis: An Overview[J]. Recent Patents on Inflammation & Allergy Drug Discovery, 2019, 13(2):134-143. [CrossRef] [PubMed] [Google Scholar]
  5. Ganguly S, Raj D, Gupta V K, et al. Giardia and giardiasis: an overview of recent developments.[J]. 2016. [Google Scholar]
  6. Perrucci Stefania, Fichi Gianluca, Ricci Enrica et al. In vitro and ex vivo evaluation of the anti-Giardia duodenalis activity of the supernatant of Slab51 (SivoMixx).[J] .PLoS One, 2019, 14: e0213385. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.